Vaccines
Bharat Biotech's iNCOVACC Covid Vaccine Approved for Public Use, Priced at Rs 800 for Private Markets
Bharat Biotech International Limited has announced the approval and pricing of its COVID-19 intranasal vaccine, iNCOVACC, marking a significant milestone in the global fight against the pandemic. The vaccine, priced at Rs 800 (excluding GST) for private markets and Rs 325 (excluding GST) for government supplies, will be rolled out